NASDAQ: TVTX Travere Therapeutics, Inc. 8-K

Travere Therapeutics reports Q1 2026 financial results

Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read

1 material change detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TVTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 5:28 PM